Descriptor English: | Acromegaly | ||||||
Descriptor Spanish: |
Acromegalia
| ||||||
Descriptor Portuguese: | Acromegalia | ||||||
Descriptor French: | Acromégalie | ||||||
Entry term(s): |
Hypersecretion Syndrome, Somatotropin (Acromegaly) Hypersecretion Syndromes, Somatotropin (Acromegaly) Inappropriate GH Secretion Syndrome (Acromegaly) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly) Pseudoacromegaly Somatotropin Hypersecretion Syndrome (Acromegaly) Somatotropin Hypersecretion Syndromes (Acromegaly) Syndrome, Somatotropin Hypersecretion (Acromegaly) Syndromes, Somatotropin Hypersecretion (Acromegaly) |
||||||
Tree number(s): |
C05.116.132.082 C10.228.140.617.738.250.100 C19.700.355.179 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000172 | ||||||
Scope note: | A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) |
||||||
Annotation: | coordinate with GROWTH HORMONE in animals or HUMAN GROWTH HORMONE in humans if pertinent |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
DeCS ID: | 178 | ||||||
Unique ID: | D000172 | ||||||
NLM Classification: | WK 550 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2009/07/06 |
|
Acromegaly
- Preferred
Pseudoacromegaly
- Related but not broader or narrower
Concept UI |
M0000261 |
Scope note | A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) |
Preferred term | Acromegaly |
Entry term(s) |
Hypersecretion Syndrome, Somatotropin (Acromegaly) Hypersecretion Syndromes, Somatotropin (Acromegaly) Inappropriate GH Secretion Syndrome (Acromegaly) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly) Somatotropin Hypersecretion Syndrome (Acromegaly) Somatotropin Hypersecretion Syndromes (Acromegaly) Syndrome, Somatotropin Hypersecretion (Acromegaly) Syndromes, Somatotropin Hypersecretion (Acromegaly) |
Concept UI |
FD00067608 |
Preferred term | Pseudoacromegaly |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey